When patients with glaucoma switched from a brand name drug to its generic counterpart, they were more likely to take their medication as directed compared to those who remained on the brand name drug, according to a new U-M Kellogg Eye Center study.
What should doctors wear? And how does something as simple as their choice of a suit, scrubs or slacks influence how patients view them? A new analysis takes a comprehensive look – and finds that the answer isn’t as simple as you might think.
The Centers for Medicare and Medicaid Services have finalized coverage guidelines for lung cancer screening with CT scans for people at high-risk of developing lung cancer. Coverage goes into effect immediately.
A tragic accident 32 years ago forever altered the lives of an entire prominent Michigan auto industry family, as a beloved wife and mother suffered a devastating traumatic brain injury, or TBI. Now, the Massey family has invested in the hope that University of Michigan medical and scientific teams can spare other families what they endured.
If you’re an older person having a major operation these days, it is very likely that your hospital is receiving a “report card” on their performance. These reports are designed to prompt hospitals to improve in areas where they perform poorly. That’s the good news. The not-so-good news: Those “report cards” do not seem to be making things better for patients.
A U-M alumna who sought to avoid passing a deadly disease to her son has given scientists a gift that could help many more families affected by the same disease: an embryo that has allowed U-M researchers to produce stem cells and nerve cells that contain the crucial disease-causing genetic defect.
Starting this week, medical students across the country are asking themselves, “If you could go anywhere in the country to train for your chosen field of medicine, where would you go?” According to new rankings, U-M should be near the top of those students’ lists, no matter what kind of doctor they want to be.
A new test can guide treatment for patients with graft versus host disease (GVHD), an often life-threatening complication of bone marrow and stem cell transplants, according to research from the University of Michigan published in Lancet Haematology this month.